AUG 31, 2021 5:00 PM PDT

A drug-free rehabilitation system for stroke survivors.

WRITTEN BY: J. Bryce Ortiz

Last week, the United States Food and Drug Administration (FDA) approved a first-of-its-kind stroke rehabilitation system. This is exciting news for rehabilitation specialists and stroke survivors. Every year, close to 800,000 individuals in the United States suffer from a stroke, which means that someone is having a stroke every 40 seconds. Individuals who survive a stroke are often faced with new daily challenges and months to years of rehabilitation to regain control of various bodily functions. 

For the past few years, researchers from various organizations have worked collectively on a novel approach called the Vivistim System, which uses vagus nerve stimulation for treating moderate to severe upper extremity mobility loss. This upper limb loss is commonly seen after ischemic stroke. Dr. Christopher M. Loftus, the acting director of the FDA’s Center for Devices and Radiological Health Office of Neurological and Physical Medicine Devices, states that, “people who have lost mobility in their hands and arm due to ischemic stroke are often limited in their treatment options […]. [The] approval of the Vivistim System offers the first stroke rehabilitation using vagus nerve stimulation.”

The Vivistim System works by electrically stimulating the vagus nerve. The vagus nerve is the longest and one of the most complex cranial nerves of the body. It carries information from the brain to many organ systems of the body and is involved in a vast array of bodily functions.   The Vivistim System, utilizes a small implantable pulse generator that is placed under the skin of a patient with a wire lead that wraps around the vagus nerve to send electrical signals.  

In a recent clinical trial testing the device, researchers studied patients who suffered from a stroke and were then implanted with the device. The researchers found that the patients implanted with the Vivistim System, in conjunction with common stroke rehabilitation, showed clinically meaningful improvements in upper extremity motor function and quality of life scores. The Vivistim System is an important and novel drug-free rehabilitation that has the potential to improve the lives of many stroke survivors. 

 

Source: FDAYouTubeMicroTransponder, Inc.The Lancet

About the Author
  • Science and medical writer | Researcher | Interested in the intersection between translational science, drug development, and policy
You May Also Like
JUL 20, 2021
Technology
Artificial Intelligence Predicts Which Drug Candidates Will Be Successful In Clinical Trials
JUL 20, 2021
Artificial Intelligence Predicts Which Drug Candidates Will Be Successful In Clinical Trials
Researchers are leveraging artificial intelligence and machine learning to help improve the rate at which drugs move suc ...
AUG 02, 2021
Microbiology
The Unique Microbiomes of Long-Lived People
AUG 02, 2021
The Unique Microbiomes of Long-Lived People
What's the secret of people that live a long life? The answer may be complex but for some, it could include the microbio ...
AUG 10, 2021
Drug Discovery & Development
Epidemiology and postexposure prophylaxis of rabies virus
AUG 10, 2021
Epidemiology and postexposure prophylaxis of rabies virus
Rabies is a viral disease that can be transmitted from an infected animal to another animal or human. In the U ...
AUG 13, 2021
Drug Discovery & Development
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
AUG 13, 2021
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis. The stu ...
SEP 26, 2021
Coronavirus
LIBRA-Seq ID's a Potent Antibody to Fight COVID-19
SEP 26, 2021
LIBRA-Seq ID's a Potent Antibody to Fight COVID-19
Humans can produce millions or even billions of antibodies, so only so many can be captured and screened. But those anti ...
OCT 15, 2021
Drug Discovery & Development
Oxytocin Therapy Shows No Benefit for Autistic Children
OCT 15, 2021
Oxytocin Therapy Shows No Benefit for Autistic Children
Intranasal oxytocin therapy does not benefit autistic children and adolescents. The corresponding study was published in ...
Loading Comments...